LBT Receives Notice of Allowance for Third Patent
Filed with ASX · · 1 page · English
Clever Culture Systems Limited on 6ix
Earlier from Clever Culture Systems
- LBT Begins Clinical Trials of APAS Technology
- LBT Innovations Completes U.S. Regulatory Submission
- LBT Concludes APAS Clinical Trial Program
Later from Clever Culture Systems
- Cochlear Executive Brent Barnes Appointed CEO of LBT
- LBT granted patent in Japan for core APAS technology
- US FDA grants approval for APAS
- LBT Innovations Granted New Patent for United States
- Completion of Placement
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems